Risk Factors of the Occurrence and Treatment Failure of Refractory Peritoneal Dialysis-Associated Peritonitis: A Single-Center Retrospective Study From China
- PMID: 38566455
- DOI: 10.1111/sdi.13202
Risk Factors of the Occurrence and Treatment Failure of Refractory Peritoneal Dialysis-Associated Peritonitis: A Single-Center Retrospective Study From China
Abstract
Background: This study aimed to investigate the clinical characteristics and prognosis of refractory peritoneal dialysis (PD)-associated peritonitis as well as the risk factors of its occurrence and treatment failure.
Methods: A single-center retrospective cohort study was conducted among 519 patients undergoing PD from January 2007 to October 2021. According to the International Society for Peritoneal Dialysis guidelines, all episodes occurred in our center were divided into two groups: refractory and nonrefractory. Demographic, biochemical, and pathogenic bacteria and treatment outcome data were collected.
Results: During the 15-year period, 282 episodes of peritonitis occurred in 166 patients undergoing PD. The refractory rate was 34.0% (96/282). Gram-positive organisms were the leading cause of peritonitis (47.9%); however, gram-negative organisms were predominant in refractory peritonitis (34.4%, p = 0.002). Multiple logistic regression revealed that gram-negative organism-based peritonitis, longer PD duration, and female sex were the significant independent predictors of refractory peritonitis. Among 96 refractory episodes, white blood cell (WBC) count, dialysate WBC on Day 3, and PD duration ≥5 years were the independent risk factors of treatment failure.
Conclusions: Gram-negative organism-based peritonitis, longer PD duration, and female sex were the independent risk factors of refractory peritonitis. Refractory peritonitis with higher WBC count, higher dialysate WBC on Day 3, and PD duration ≥5 years increased treatment failure risk and required immediate PD catheter removal. The timely identification of refractory peritonitis with high risk of treatment failure as well as timely PD catheter removal is important.
Keywords: peritoneal dialysis; peritoneal dialysis‐associated peritonitis; refractory peritonitis.
© 2024 The Authors. Seminars in Dialysis published by Wiley Periodicals LLC.
Similar articles
-
Clinical outcomes in peritoneal dialysis with refractory peritonitis: significance of the day 5 cell count.Clin Exp Nephrol. 2025 Feb;29(2):221-226. doi: 10.1007/s10157-024-02564-w. Epub 2024 Oct 5. Clin Exp Nephrol. 2025. PMID: 39368015
-
Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National Registry.Am J Kidney Dis. 2018 Jun;71(6):814-821. doi: 10.1053/j.ajkd.2017.10.017. Epub 2017 Dec 28. Am J Kidney Dis. 2018. PMID: 29289475
-
Predictors of outcome following bacterial peritonitis in peritoneal dialysis.Perit Dial Int. 2002 Sep-Oct;22(5):573-81. Perit Dial Int. 2002. PMID: 12455568
-
Mycobacterium abscessus - an uncommon, but important cause of peritoneal dialysis-associated peritonitis - case report and literature review.BMC Nephrol. 2020 Nov 17;21(1):491. doi: 10.1186/s12882-020-02146-4. BMC Nephrol. 2020. PMID: 33203375 Free PMC article. Review.
-
Does the Use of Gastric-Acid Suppressants Increase the Risk of Peritonitis in Patients Undergoing Peritoneal Dialysis? A Meta-Analysis.Semin Dial. 2024 Nov-Oct;37(6):424-432. doi: 10.1111/sdi.13226. Epub 2024 Aug 25. Semin Dial. 2024. PMID: 39182173 Review.
Cited by
-
A predictive model of treatment effectiveness of refractory peritoneal dialysis-related peritonitis in patients with peritoneal dialysis: a single-center observational study in South China.Clin Kidney J. 2024 Oct 29;17(12):sfae332. doi: 10.1093/ckj/sfae332. eCollection 2024 Dec. Clin Kidney J. 2024. PMID: 39664994 Free PMC article.
-
A Case of Refractory Peritoneal Dialysis-Related Peritonitis Caused by Streptococcus gordonii.Cureus. 2025 Jan 10;17(1):e77248. doi: 10.7759/cureus.77248. eCollection 2025 Jan. Cureus. 2025. PMID: 39925597 Free PMC article.
References
-
- P. Li, K. Chow, Y. Cho, et al., “ISPD Peritonitis Guideline Recommendations: 2022 Update on Prevention and Treatment,” Peritoneal Dialysis International 42, no. 2 (2022): 110–153, https://doi.org/10.1177/08968608221080586.
-
- V. Thammishetti, A. Kaul, D. S. Bhadauria, et al., “A Retrospective Analysis of Etiology and Outcomes of Refractory CAPD Peritonitis in a Tertiary Care Center From North India,” Peritoneal Dialysis International 38, no. 6 (2018): 441–446.
-
- P. K. Li, C. C. Szeto, B. Piraino, et al., “Peritoneal Dialysis‐Related Infections Recommendations: 2010 Update,” Peritoneal Dialysis International 30, no. 4 (2010): 393–423.
-
- P. K. Li, C. C. Szeto, B. Piraino, et al., “ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment,” Peritoneal Dialysis International 36, no. 5 (2016): 481–508.
-
- C.‐T. Chao, S.‐Y. Lee, W.‐S. Yang, et al., “Viridans Streptococci in Peritoneal Dialysis Peritonitis: Clinical Courses and Long‐Term Outcomes,” Peritoneal Dialysis International 35, no. 3 (2015): 333–341.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical